Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Share News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.325
Bid: 1.30
Ask: 1.35
Change: -0.075 (-5.36%)
Spread: 0.05 (3.846%)
Open: 1.40
High: 1.40
Low: 1.25
Prev. Close: 1.40
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Powerhouse resolves claim; PCI-PAL wins court case

Wed, 22nd May 2024 21:05

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

STS Global Income & Growth Trust - has a "balanced portfolio constructed from global equities" - Says net asset value at March 31 was 223.71 pence up from 220.37p a year prior. Adds the NAV total return for the year was 4.8%, and the share price total return was 6.1%, compared to a total return of 11.5% in the Lipper Global - Equity Global Income Index. This compares to a net asset value total return of negative 1.8%, a share price total return of negative 4.8% and a total return of 0.5% in the Lipper Global - Equity Global Income Index in the previous year. Announces fourth quarterly dividend of 1.525p per share.

----------

Orcadian Energy PLC - oil and gas development company - Announces that it has agreed a non-binding heads of agreement with a potential farm-in partner on its recently awarded SNS Licence. This grants the potential partner a period of commercial exclusivity. This runs to the end of 2024. Under the terms, an affiliate of the partner agrees a loan of USD1.4 million to Orcadian for up to two years.

----------

Powerhouse Energy Group PLC - Bingley, England-based non-recyclable waste-to-energy conversion company - Announces that the claim originally issued in October by GetGo Recycling Ltd, now called Onunda Ltd, against its European patent and patent applications has been resolved. Explains an agreement has been reached to resolve the issues and the company looks forward to progressing its other patent applications within Europe and the rest of the world. The agreement ensures that no additional challenge to Powerhouse's patents worldwide will be raised by Onunda or any of its group companies, now or in the future.

----------

Future PLC - Bath, England-based online magazine publisher and owner of price comparison website Go Compare - Starts the previously announced GBP45 million share buyback programme.

----------

Neometals Ltd - London-based battery materials producer - Says the final electrolysis stage of ELi Process pilot trials has commenced in Canada at NESi, the testing facility of electrolyser vendor, NORAM. The test work will electrolyse a purified lithium chloride solution from an operating South American brine source and produce lithium hydroxide as the primary product. The long-duration component of the trial will provide data confirming expected power consumption, membrane life and product quality to support ongoing technology licensing activities.

----------

Bradda Head Lithium Ltd - North American-focused lithium explorer - Provides an update on work at its Basin project in Arizona. Says the lithium-in-clay, resource-expansion drilling programme has concluded with the completion of eight drill holes on the Basin North target portion of the Basin project. Notes a resource expansion from 1.08 million tons to a minimum of 2.5 MT of lithium carbonate equivalent would generate a USD3 million royalty payment to Bradda Head from Lithium Royalty Co. To date, notes partial results have been received, with the remainder still pending.

----------

Warpaint London PLC - Buckinghamshire-based colour cosmetics supplier, which owns the W7 and Technic brands - Announces that its ordinary shares have been approved to trade on the OTCQX Best Market in the US. Trading starts Wednesday. Will continue to trade on the AIM market of the London Stock Exchange. Believes this will provide enhanced investor benefits, including easier trading access for certain investors located in the US, and greater liquidity due to a broader geographic pool of potential investors.

----------

Zotefoams PLC - cellular material technology provider - Provides a positive trading update for the four months ended April ahead of Wednesday's annual general meeting. Says trading in the period has been strong, with the group sustaining the positive momentum seen in financial 2023 to deliver overall sales growth of 14% and record revenue. Highlights a 46% increase in high-performance products sales but notes Polyolefin Foams sales declined 7%. Full-year expectations remain unchanged. Further, as previously announced David Stirling steps down as chief executive after the AGM.

----------

The Artisanal Spirits Co PLC - Edinburgh, Scotland-based distiller of single-cask and limited-edition whiskies - Issues trading update ahead of Wednesday's annual general meeting. Confirms that the positive profit improvement momentum from the second half of financial 2023 has continued into early financial 2024, with first quarter earnings before interest, tax, depreciation and amortisation up by over GBP0.5 million versus the prior year. This performance is slightly ahead of expectations. Continue to anticipate full year consensus revenue growth of mid-single digit percentage year on year. Remains on track to meet full year consensus Ebitda of GBP1 million.

----------

Ilika PLC - Romsey, England-based solid-state battery technology company - Announces the start of testing of its initial batch of P1 Goliath electric vehicle prototype batteries in a customer-sponsored programme. This follows the successful completion of production and in-house testing. Chief Executive Graeme Purdy states: "Ilika has successfully delivered another milestone on its Goliath roadmap. We are delighted to be engaging with a portfolio of interested OEMs and Tier 1 companies on commercially sponsored evaluation programmes. We continue to progress towards commercialisation as planned and remain on track to demonstrate our Goliath technology at pilot scale to underpin licensing discussions and technology transfer. Our near-term focus is on increasing battery testing capacity and upgrading our dry rooms, with development strongly aligned to the market growth and structural drivers within the EV sector."

----------

Regional REIT Ltd - commercial property investor - Issues trading update for the quarter to March. Says gross property assets were worth GBP688.2 million at the end of the first-quarter, falling 1.8% from GBP700.7 million at the end of December. Rent roll totals GBP65.5 million down from GBP67.8 million at December 31, EPRA occupancy is at 79.9% down slightly from 80.0%. Total rent collection for the quarter is currently at 97.2%, up on-year from 96.3%. It adds: "Although the inflationary backdrop continues to impact the economy, there are signs that inflation is heading back towards the Bank of England's two percent target, allowing for a more favourable outlook for the company." Says will pay dividend of 1.20 pence per share for the quarter.

----------

Polarean Imaging PLC - medical imaging technology developer - Raises USD10 million via placing and subscription announced Monday at 1 pence per share. Notes the subscription included an investment from existing investors NUKEM Isotopes GmbH and Bracco Imaging SpA and certain Directors and management of the company. NUKEM invests USD2.5 million, and Bracco USD2 million. Directors and management invest USD321,000. Proceeds will be used to accelerate commercialisation of XENOVIEW, to support the continued investment in research and development. Further, plans to raises USD2.5 million via open offer to shareholders. Terms of open offer are 9 open offer shares for every 10 existing ordinary shares held at a price of 1p per open offer share.

----------

PCI-PAL PLC - London-based cloud payment and data protection solutions provider - Announces that the Court of Appeal for England & Wales has ruled in its favour in the unfounded patent litigation case brought by its competitor Sycurio Ltd. Court dismisses appeal and upholds original ruling. Court awards damages to PCI-PAL of GBP1.1 million.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
21 May 2024 20:23

Polarean Imaging to raise USD10 million via placing and subscription

(Alliance News) - Polarean Imaging PLC on Tuesday said that it intends to raise a minimum of USD10 million via a placing to institutional and other investors, and a direct subscription with the company.

Read more
10 May 2024 12:00

LONDON MARKET MIDDAY: FTSE 100 hits record high on BoE vote, UK GDP

(Alliance News) - Stock prices in London were up at midday on Friday, hitting a record high once again as investors reacted positively to a dovish Bank of England interest rates hold.

Read more
10 May 2024 11:57

Polarean shares jump on MRI system order

(Sharecast News) - Advanced MRI technology specialist Polarean Imaging shares were surging on Friday, after receiving its second de novo order for a new Xenon MRI System from the University of Alabama at Birmingham (UAB) Hospital.

Read more
10 May 2024 11:40

Polarean shares soar on University of Alabama deal for Xenon MRI

(Alliance News) - Polarean Imaging PLC on Friday said it has received its second de novo order for a new Xenon MRI system from the University of Alabama at Birmingham Hospital in the US.

Read more
10 May 2024 10:59

AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
3 May 2024 15:40

IN BRIEF: Polarean Imaging wins order for new polariser

Polarean Imaging PLC - London-based medical imaging technology developer - Receives an order for a new polariser to replace the research polariser at Cincinnati Children's Hospital Medical Center. "Cincinnati Children's previously purchased the first clinical polariser and continues to demonstrate a commitment to the future of Xenon MRI for challenging lung diseases. Cincinnati Children's performs hospital clinical imaging on both children and adults (from their neighbouring partner institution, UC Medical Centre)," Polarean says.

Read more
3 May 2024 11:46

Polarean gets new polariser order from Cincinnati Children's

(Sharecast News) - Polarean Imaging announced a new polariser order to replace the research polariser at Cincinnati Children's Hospital Medical Center on Friday.

Read more
16 Apr 2024 20:16

TRADING UPDATES: Nexteq confident of meeting full-year expectations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
29 Feb 2024 14:28

Polarean Imaging shares sink after announcing a costly strategic plan

(Alliance News) - Polarean Imaging PLC shares dropped on Thursday, after the company said it would need to find an additional USD10 million to finance its medium-term ambitions.

Read more
15 Jan 2024 11:21

IN BRIEF: Polarean Imaging strategic parter raises stake to above 10%

Polarean Imaging PLC - London-based developer of medical imaging devices providing magnetic resonance imaging of the lungs - Strategic partner NUKEM Isotopes GmbH buys 9.5 million Polarean shares from Amati Global Investors Ltd, raising its stake to 10.5% from 6.1%. Alzenau, Germany-based NUKEM is a trading company in stable isotopes and noble gases. Amati retains a 4.6% stake in Polarean, down from its last reported level of 9.8%. The shares purchased by NUKEM are worth GBP725,800 at Polarean's current market price.

Read more
7 Dec 2023 16:01

Polarean gets first de novo order for Xenoview polariser

(Sharecast News) - Lung-focussed MRI technology developer Polarean Imaging said in an update on Thursday that it has received its first de novo order for a new Xenoview polariser.

Read more
7 Dec 2023 12:14

IN BRIEF: Polarean shares jump on Xenoview polariser order

Polarean Imaging PLC - London-based medical imaging technology developer - Receives its first de novo order for a new Xenoview polariser from an unnamed "top-tier" academic medical centre located in the northeast of the US. Polarean says it continues to have positive meetings and is in active negotiations with additional academic medical centres. Xenoview is a hyperpolarised contrast agent for use with magnetic imaging for the evaluation of lung ventilation in adults and paediatric patients aged 12 years and older. It was approved for use in the US last year.

Read more
7 Dec 2023 11:11

AIM WINNERS & LOSERS: Smart Metering accepts offer; order for Polarean

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
8 Sep 2023 14:12

Polarean Imaging enters strategic partnership with VIDA Diagnostics

(Sharecast News) - Advanced MRI technology specialist Polarean Imaging announced a strategic partnership with a clinical imaging intelligence company VIDA Diagnostics on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.